Article Listing - S-P gains exclusive rights to Asmanex/Foradil product

CYTOTHERAPEUTICS

10 February 1992

Thomas Wiggans has been named as chief operating officer of Cytotherapeutics.

SYNTHECELL

10 February 1992

John Byington becomes president of Synthecell and also of its wholly-owned subsidiary company, Genetic Medisyn.

UPJOHN'S HALCION

10 February 1992

Shareholders of the US pharmaceutical concern Upjohn (see also page 4) have filed a lawsuit which accuses the company's senior...

TANABE PHARMA IN FRANCE

10 February 1992

Japanese concern Tanabe Seiyaku has set up a subsidiary in Paris, France, to develop medical products. The subsidiary, which is...

ROMANIAN MEDICINES TO RUSSIA

10 February 1992

Romania is to export unspecified quantities of medicines and drugs to the Russian Federation this year, following the signing of...

UK DRUG STOCKS BULL RUN OVER?

10 February 1992

The performance of stocks in the UK's Health and Household sector, after a strong start to the New Year, came...

OTC PRODUCTS IN EIRE

10 February 1992

The market for over-the-counter medicinal products in Ireland reached a value of almost IRL39 million ($65 million) last year. This...

ITALIAN DRUG SPENDING FORECASTS "ARE FOLLY"

10 February 1992

Federfarma, the Italian federation of pharmacists, disagrees with state estimates that the regional governments will pick up a bill of...

CALCITRIOL BENEFIT FOR OSTEOPOROSIS

10 February 1992

Favorable results from a study involving Hoffmann-La Roche's calcitriol have been published by a New Zealand group led by Murray...

MERCK'S PROSCAR NEARING US APPROVAL

10 February 1992

With US Food and Drug Administration advisory panel recommendation of Merck & Co's Proscar (finasteride) last week, as an orally-active...

Showing 94821-94830 of 95372 articles

Go to beginningPreviousNextGo to end